Eli Lilly and Co.

Eli Lilly, founded 1876, is a global biopharma leader with a diverse portfolio in diabetes (Jardiance, Trulicity), oncology (Cyramza, Verzenio), obesity (Zepbound) and rare diseases. Strategic collaborations expand innovation and growth.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Professional Services
Industry: Biotechnology Research

Employees: 47,000
HQ: Indianapolis

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
LLY	Eli Lilly and Co. Cap: 929.8B \| P/E: 50.2	EQUITY	NYQ	USD	US5324571083	Active	📈